Zerodha (Trading Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Track all the latest updates and news of Eris Lifesciences IPO.
August 22, 2024 8:49:00 PM
New Delhi, Aug 22 (PTI) Private equity major ChrysCapital on Thursday exited Eris Lifesciences by selling its entire 7.27 per cent stake in the company for Rs 1,187 crore via open market ...
Published by : MSNOctober 28, 2024 9:20:00 PM
Eris Lifesciences’ (ERIS) Q2FY25 EBITDA was in line with our estimate (Rs2.65bn; 46% YoY). Eris has opted for inorganic route to diversify and scale up existing portfolio. This has been ...
Published by : moneycontrol.comNovember 14, 2024 3:30:00 AM
The stock debuted at Rs 612 on BSE compared with the initial public offer (IPO) price of Rs 603.In October 2017, Eris Lifesciences Ltd (Eris) acquired the entire shareholding of UTH Healthcare Ltd ...
Published by : India InfolineNovember 21, 2024 3:30:00 AM
ERIS Lifesciences Ltd share price was down by -0.11% from the previous closing price of ?1,368.45. Who are peers of ERIS Lifesciences Ltd? The peers of ERIS Lifesciences Ltd are Sun ...
Published by : Business TodayMarch 17, 2016 7:30:00 PM
Prabhudas Lilladher is bullish on Eris Lifesciences has recommended buy rating on the stock with a target price of Rs 1420 in its research report dated October 26, 2024. Prabhudas Lilladher is ...
Published by : moneycontrol.comDecember 13, 2023 10:30:00 PM
Eris Lifesciences Announces Entry into India’s Insulin Market Eris Lifesciences today announced its entry into India’s INR 35-40 bn Insulin and GLP1 agonists market through Eris MJ Biopharm ...
Published by : health.economictimes.indiatimesEris Lifesciences IPO Listing Date
› Listing Date: Thursday, June 29, 2017
› BSE Script Code: 540596
› NSE Symbol: ERIS
› Listing In: ‘B’ Group of Securities
› ISIN: INE406M01024
› Issue Price: Rs 603 Per Equity Share
› Face Value: Rs 1 Per Equity Share
Eris Lifesciences IPO allotment stautus is now available online.
Eris Lifesciences Limited IPO to open on Jun 16, 2017 and close for subscription on Jun 20, 2017. The price band for the issue has been fixed at Rs 600 at lower level and Rs 603 at upper level. The equity shares of the company to be list at BSE and NSE.
Eris Lifesciences Ltd is entering in the capital market with an Offer for Sale of 28,875,000 Equity Shares of Rs 1. The price band for the issue has been fixed at Rs 600 at lower level and Rs 603 at upper level.
Eris Lifescience Ltd is Ahmedabad, Gujrat based pharmaceutical company engaged in research, development, manufacturing and selling of select therapeutic areas within the chronic and acute categories of the Indian Pharmaceutical Market.
The issue opens on Jun 16, 2017 and closes for subscription on Jun 20, 2017. The equity shares of the issue are proposed to be list on the Bombay Stock Exchange (BSE) and National Stock Exchange (NSE).
The Eris Lifesciences IPO is proposed to open on June 16, 2017. The IPO application ends on June 20, 2017.
Retail investors can apply in the retail or non-institutional investor category from June 16, 2017 to June 20, 2017. The Eris Lifesciences IPO can be applied online through Net Bank (ASBA method) or the stock broker (UPI method).
The Eris Lifesciences IPO will open for subscription on June 16, 2017. The public issue will close on June 20, 2017.
Useful Articles
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
RHP
